35277554|t|Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy.
35277554|a|Mitochondrial defects result in dysregulation of metabolomics and energy homeostasis that are detected in upper motor neurons (UMNs) with TDP-43 pathology, a pathology that is predominantly present in both familial and sporadic cases of amyotrophic lateral sclerosis (ALS). While same mitochondrial problems are present in the UMNs of ALS patients with TDP-43 pathology and UMNs of TDP-43 mouse models, and since pathologies are shared at a cellular level, regardless of species, we first analyzed the metabolite profile of both healthy and diseased motor cortex to investigate whether metabolomic changes occur with respect to TDP-43 pathology. High-performance liquid chromatography, high-resolution mass spectrometry and tandem mass spectrometry (HPLC-MS/MS) for metabolite profiling began to suggest that reduced levels of NAD+ is one of the underlying causes of metabolomic problems. Since nicotinamide mononucleotide (NMN) was reported to restore NAD+ levels, we next investigated whether NMN treatment would improve the health of diseased corticospinal motor neurons (CSMN, a.k.a. UMN in mice). prpTDP-43A315T-UeGFP mice, the CSMN reporter line with TDP-43 pathology, allowed cell-type specific responses of CSMN to NMN treatment to be assessed in vitro. Our results show that metabolomic defects occur early in ALS motor cortex and establishing NAD+ balance could offer therapeutic benefit to UMNs with TDP-43 pathology.
35277554	0	27	Mitochondrial dysregulation	Disease	MESH:D021081
35277554	44	47	ALS	Disease	MESH:D000690
35277554	66	72	TDP-43	Gene	23435
35277554	108	112	NAD+	Chemical	MESH:D009243
35277554	148	169	Mitochondrial defects	Disease	MESH:C565376
35277554	286	292	TDP-43	Gene	23435
35277554	385	414	amyotrophic lateral sclerosis	Disease	MESH:D000690
35277554	416	419	ALS	Disease	MESH:D000690
35277554	433	446	mitochondrial	Disease	MESH:D028361
35277554	483	486	ALS	Disease	MESH:D000690
35277554	487	495	patients	Species	9606
35277554	501	507	TDP-43	Gene	23435
35277554	530	536	TDP-43	Gene	230908
35277554	537	542	mouse	Species	10090
35277554	776	782	TDP-43	Gene	23435
35277554	975	979	NAD+	Chemical	MESH:D009243
35277554	1043	1070	nicotinamide mononucleotide	Chemical	MESH:D009537
35277554	1072	1075	NMN	Chemical	MESH:D009537
35277554	1101	1105	NAD+	Chemical	MESH:D009243
35277554	1143	1146	NMN	Chemical	MESH:D009537
35277554	1223	1227	CSMN	Disease	MESH:D016472
35277554	1236	1239	UMN	Disease	
35277554	1243	1247	mice	Species	10090
35277554	1271	1275	mice	Species	10090
35277554	1281	1285	CSMN	Disease	MESH:D016472
35277554	1305	1311	TDP-43	Gene	230908
35277554	1363	1367	CSMN	Disease	MESH:D016472
35277554	1371	1374	NMN	Chemical	MESH:D009537
35277554	1467	1470	ALS	Disease	MESH:D000690
35277554	1501	1505	NAD+	Chemical	MESH:D009243
35277554	1559	1565	TDP-43	Gene	23435
35277554	Association	MESH:C565376	23435
35277554	Association	MESH:D000690	23435
35277554	Association	MESH:D021081	23435
35277554	Association	MESH:D016472	230908
35277554	Negative_Correlation	MESH:D009243	MESH:D009537
35277554	Association	MESH:D028361	23435
35277554	Negative_Correlation	MESH:D009537	MESH:D016472

